miR-211 and MITF modulation by Bcl-2 protein in melanoma cells

Autor: De Luca T, Pelosi A, Daniela Trisciuoglio, D'Aguanno S, Desideri M, Farini V, Di Martile M, Bellei B, Mg, Tupone, Candiloro A, Regazzo G, Mg, Rizzo, Del Bufalo D

Publikováno v: Europe PubMed Central

Melanoma, the most lethal form of skin cancer, is frequently associated with alterations in several genes, among which the Bcl-2 oncogene plays an important role in progression, chemosensitivity and angiogenesis. Also microRNA (miRNA) are emerging as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8c812a842de6667572741add83607559
https://pubmed.ncbi.nlm.nih.gov/26599548

Growth-factor regulation of mdm-2 messenger-RNA expression

Autor: Renato Baserga, Zl Fei, Mg Rizzo

Publikováno v: ResearcherID

We have investigated the growth factor regulation of mdm-2 mRNA levels in mouse embryo fibroblasts, whose growth is controlled by platelet-derived growth factor (PDGF) and insulin-like growth factor I (IGF-I). We find that both growth factors up-regu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::155af5335c3feea966a7422d34c16ee6
https://pubmed.ncbi.nlm.nih.gov/21607424

EPS T14 from Bacillus licheniformis Prevents Infection of Human Nasal Epithelial Cells by Respiratory Viruses.

Autor: Pezzino G; Laboratory of Immunology and Biotherapy, Department Human Pathology 'G. Barresi', University of Messina, Messina, Italy., Calabrò A; Laboratory of Immunology and Biotherapy, Department Human Pathology 'G. Barresi', University of Messina, Messina, Italy., Drommi F; Laboratory of Immunology and Biotherapy, Department Human Pathology 'G. Barresi', University of Messina, Messina, Italy., Campana S; Laboratory of Immunology and Biotherapy, Department Human Pathology 'G. Barresi', University of Messina, Messina, Italy., Cavaliere R; Laboratory of Immunology and Biotherapy, Department Human Pathology 'G. Barresi', University of Messina, Messina, Italy.; Division of Clinical Pathology, University Hospital Policlinico G. Martino, Messina, Italy., Bonaccorsi I; Laboratory of Immunology and Biotherapy, Department Human Pathology 'G. Barresi', University of Messina, Messina, Italy., Carrega P; Laboratory of Immunology and Biotherapy, Department Human Pathology 'G. Barresi', University of Messina, Messina, Italy., Zammuto V; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy.; Research Centre for Extreme Environments and Extremophiles, Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy.; ATHENA Green Solutions S.r.l., Messina, Italy., Rizzo MG; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy., Gugliandolo C; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy.; Research Centre for Extreme Environments and Extremophiles, Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy., Ferlazzo G; Department of Experimental Medicine (DIMES), University of Genoa, Genova, Italy.; Unit of Experimental Pathology and Immunology, IRCCS Ospedale Policlinico San Martino, Genova, Italy., De Pasquale C; Laboratory of Immunology and Biotherapy, Department Human Pathology 'G. Barresi', University of Messina, Messina, Italy.

Publikováno v: ImmunoTargets and therapy [Immunotargets Ther] 2024 Sep 27; Vol. 13, pp. 487-499. Date of Electronic Publication: 2024 Sep 27 (Print Publication: 2024).

Exploring the relationship between performance feedback and medical managers' budgetary performance:The role of managerial self-efficacy.

Autor: Rizzo MG; Dipartimento di Scienze dell'economia e della gestione aziendale, Facoltà di Economia, Universita Cattolica del Sacro Cuore, Milano, Italy.

Publikováno v: Health services management research [Health Serv Manage Res] 2024 Aug; Vol. 37 (3), pp. 135-142. Date of Electronic Publication: 2023 May 29.

Efficacy and safety of biosimilar Peg-filgrastim after autologous stem cell transplant in myeloma and lymphoma patients: a comparative study with biosimilar Filgrastim, Lenograstim, and originator Peg-filgrastim.

Autor: Marchesi F; Hematology Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 55, 00144, Rome, Italy. francesco.marchesi@ifo.it., Terrenato I; Department of Research, Advanced Diagnostics and Technological Innovation, Clinical Trial Center, Biostatistics and Bioinformatics Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Papa E; Hematology Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 55, 00144, Rome, Italy., Tomassi M; Hematology Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 55, 00144, Rome, Italy., Falcucci P; Hematology Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 55, 00144, Rome, Italy., Gumenyuk S; Hematology Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 55, 00144, Rome, Italy., Palombi F; Hematology Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 55, 00144, Rome, Italy., Pisani F; Hematology Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 55, 00144, Rome, Italy., Renzi D; Hematology Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 55, 00144, Rome, Italy., Romano A; Hematology Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 55, 00144, Rome, Italy., Spadea A; Hematology Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 55, 00144, Rome, Italy., Regazzo G; Department of Research, Advanced Diagnostics and Technological Innovation, Genomic and Epigenetic Unit, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Rizzo MG; Department of Research, Advanced Diagnostics and Technological Innovation, Genomic and Epigenetic Unit, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy., De Rienzo M; Immuno-Transfusional Medicine Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Ripellino C; Health Economics & Real-World Evidence Freelance, Milan, Italy., Sgromo S; Hematology Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 55, 00144, Rome, Italy., Viggiani C; Hematology Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 55, 00144, Rome, Italy., Ponte E; Leukapheresis and Cellular Therapy Unit, S. Camillo-Forlanini Hospital, Rome, Italy., Kayal R; Radiology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Cordone I; Clinical Pathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Foddai ML; Immuno-Transfusional Medicine Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Mengarelli A; Hematology Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 55, 00144, Rome, Italy.

Publikováno v: Annals of hematology [Ann Hematol] 2024 Mar; Vol. 103 (3), pp. 947-956. Date of Electronic Publication: 2024 Jan 08.